Published in Drug Week, February 29th, 2008
"All patients received up to six infusions of zoledronic acid (4mg, given intravenously over 15 minutes, every 3 - 4 weeks). Safety was assessed by monitoring a'dverse events and serum creatinine levels. Efficacy was assessed by monitoring skeletal-related events, brief pain inventory score, quality of life score, type of pain medication, and analgesic score. Mean age of...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.